Papers
1
Total Citations
6
H-Index
1
About
Dr. Donna Carr is a pioneering researcher in the field of antibacterial pharmacodynamics and automated microbiological assay development. Her work focuses on revolutionizing how bacterial growth is measured in dynamic in vitro systems, addressing a critical bottleneck in antibiotic dosing strategy research. Carr’s most notable contribution is the development of a fully automated platform for agar-based measurement of viable bacterial growth, detailed in her 2022 paper (6 citations). This innovation dramatically reduces the labor-intensive sampling and quantification required for pharmacodynamic studies, enabling more efficient and high-throughput evaluation of effective dosing regimens before in vivo translation. By automating the monitoring of bacterial load, her platform enhances the precision and scalability of antibacterial research. Though early in its citation impact, this work represents a significant methodological advance that promises to accelerate the development of optimized antibiotic therapies. Carr’s dedication to streamlining preclinical workflows positions her as a key innovator in the fight against antimicrobial resistance, offering researchers a powerful tool to combat one of modern medicine’s greatest challenges.
Research Focus
Key Achievements
Top Papers
- 1